<VariationArchive VariationID="15680" VariationName="NC_000016.10:g.174045_192395del" VariationType="Deletion" Accession="VCV000015680" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-05-01" DateCreated="2013-04-04" MostRecentSubmission="2022-11-13">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="30719" VariationID="15680">
      <GeneList>
        <Gene Symbol="HBA1" FullName="hemoglobin subunit alpha 1" GeneID="3039" HGNC_ID="HGNC:4823" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>16p13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="176680" stop="177522" display_start="176680" display_stop="177522" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="226678" stop="227519" display_start="226678" display_stop="227519" Strand="+" />
          </Location>
          <OMIM>141800</OMIM>
        </Gene>
        <Gene Symbol="HBA2" FullName="hemoglobin subunit alpha 2" GeneID="3040" HGNC_ID="HGNC:4824" Source="submitted" RelationshipType="near gene, downstream">
          <Location>
            <CytogeneticLocation>16p13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="172876" stop="173710" display_start="172876" display_stop="173710" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="222845" stop="223708" display_start="222845" display_stop="223708" Strand="+" />
          </Location>
          <OMIM>141850</OMIM>
        </Gene>
        <Gene Symbol="HBQ1" FullName="hemoglobin subunit theta 1" GeneID="3049" HGNC_ID="HGNC:4833" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>16p13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="180459" stop="181179" display_start="180459" display_stop="181179" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="230332" stop="231177" display_start="230332" display_stop="231177" Strand="+" />
          </Location>
          <OMIM>142240</OMIM>
        </Gene>
        <Gene Symbol="LOC106804613" FullName="hemoglobin subunit alpha 1 recombination region" GeneID="106804613" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>16p13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="174618" stop="177541" display_start="174618" display_stop="177541" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC130058090" FullName="ATAC-STARR-seq lymphoblastoid active region 10202" GeneID="130058090" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>16p13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="180960" stop="181219" display_start="180960" display_stop="181219" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC130058091" FullName="ATAC-STARR-seq lymphoblastoid silent region 6903" GeneID="130058091" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>16p13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="181230" stop="181579" display_start="181230" display_stop="181579" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LUC7L" FullName="LUC7 like" GeneID="55692" HGNC_ID="HGNC:6723" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>16p13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="188990" stop="229449" display_start="188990" display_stop="229449" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="238969" stop="279448" display_start="238969" display_stop="279448" Strand="-" />
          </Location>
          <OMIM>607782</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000016.10:g.174045_192395del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>16p13.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="174045" stop="192395" display_start="174045" display_stop="192395" variantLength="18351" />
      </Location>
      <OtherNameList>
        <Name>HBA2, METHYLATION SILENCING DUE TO ANTISENSE TRANSCRIPT</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.174045_192395del" Assembly="GRCh38">
            <Expression>NC_000016.10:g.174045_192395del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="141850.0057" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff provided an HGVS expression for OMIM allelic variant 141850.0057 from the statement in the paper by Barbour et al., 2000 (PubMed 10910890) that "breakpoints lie between coordinates 164 044-45 and 182 395-96".  Their numbering system is based on the placement of  Z84812.1, which is offset by 10000 N in NC_000016.10.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000016.10:g.174045_192395del AND Alpha-thalassemia, zf type" Accession="RCV000016969" Version="27">
        <ClassifiedConditionList TraitSetID="4902">
          <ClassifiedCondition DB="MedGen" ID="C4016157">Alpha-thalassemia, zf type</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2003-06-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2003-06-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2013-04-04" MostRecentSubmission="2022-11-13">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10910890</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12730694</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">35190856</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="4902" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="12174" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Alpha-thalassemia, zf type</ElementValue>
              </Name>
              <XRef ID="C4016157" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="37241" SubmissionDate="2013-03-28" DateLastUpdated="2022-11-13" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="141850.0057_ALPHA-THALASSEMIA, ZF TYPE" title="HBA2, METHYLATION SILENCING DUE TO ANTISENSE TRANSCRIPT_ALPHA-THALASSEMIA, ZF TYPE" />
        <ClinVarAccession Accession="SCV000037241" DateUpdated="2022-11-13" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2003-06-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Barbour et al. (2000) reported an individual (called ZF) with alpha-thalassemia due to a unique deletion (called alpha(-)-ZF) that removed the HBA1 gene (141800) and the HBQ1 gene (142240) and juxtaposed a region that normally lies approximately 18 kb downstream of the alpha-globin cluster to a site next to the structurally normal HBA2 gene. The alpha(-)-ZF deletion did not remove any positive cis-acting sequences, but expression of the structurally intact alpha-globin gene was stably silenced and, during development, its CpG island became densely methylated and insensitive to endonucleases over a region of approximately 2 kb. Tufarelli et al. (2003) showed that the deletion had truncated the widely expressed gene LUC7L (607782), which is transcribed from the opposite DNA strand. They showed that in the affected individual, in a transgenic model, and in differentiating embryonic stem cells, transcription of antisense RNA mediated silencing and methylation of the associated CpG island. This was identified as a novel mechanism underlying human genetic disease.</Attribute>
              <Citation>
                <ID Source="PubMed">10910890</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">12730694</ID>
              </Citation>
              <XRef DB="OMIM" ID="141800" Type="MIM" />
              <XRef DB="OMIM" ID="142240" Type="MIM" />
              <XRef DB="OMIM" ID="607782" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a review of epimutation mechanisms in metabolic disorders including ZF-type alpha-thalassemia, Gueant et al. (2022) discussed that, in a mouse stem cell model, promotor methylation was triggered by antisense LUC7L transcription, which occurred during cell differentiation (as opposed to the epimutation being present in germ cells). Thus, the epimutation was not considered to be constitutional.</Attribute>
              <Citation>
                <ID Source="PubMed">35190856</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HBA2" />
          </GeneList>
          <Name>HBA2, METHYLATION SILENCING DUE TO ANTISENSE TRANSCRIPT</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">METHYLATION SILENCING DUE TO ANTISENSE TRANSCRIPT</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="141850.0057" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ALPHA-THALASSEMIA, ZF TYPE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="37241" TraitType="Disease" MappingType="Name" MappingValue="ALPHA-THALASSEMIA, ZF TYPE" MappingRef="Preferred">
        <MedGen CUI="C4016157" Name="Alpha-thalassemia, zf type" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

